Development of leptomeningeal carcinomatosis during a marked response of brain metastases to pembrolizumab in a patient with non-small-cell lung cancer.

Otsubo, K; Seki, N; Nakanishi, Y; Okamoto, I

Otsubo, K; Seki, N; Nakanishi, Y; Okamoto, I.

Affiliation

Otsubo K; Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Seki N; Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Nakanishi Y; Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Okamoto I; Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. Electronic address: okamotoi@kokyu.med.kyushu-u.ac.jp.

Ann Oncol ; 29(3): 780-781, 2018 03 01.

Article in En | MEDLINE | ID: mdl-29088405

Subject(s)

Adenocarcinoma of Lung/drug therapy; Antineoplastic Agents, Immunological/therapeutic use; Brain Neoplasms/drug therapy; Brain Neoplasms/secondary; Meningeal Carcinomatosis/secondary; Adenocarcinoma of Lung/secondary; Humans; Male; Middle Aged

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Meningeal Carcinomatosis / Antineoplastic Agents, Immunological / Adenocarcinoma of Lung Limits: Humans / Male / Middle aged Language: En Journal: Ann Oncol Year: 2018 Document type: Article

Fulltext

XML

PubMed Links

Search on Google